HER2-positive Gastric Cancer Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
HER2-positive Gastric CancerAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren30 enrolled8 locationsNCT05715931
Recruiting
Phase 1Phase 2
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Adenocarcinoma
Zhejiang Cancer Hospital35 enrolled1 locationNCT06572319